Published on in Vol 3, No 4 (2019): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13286, first published .
Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Journals

  1. Fan K, Mandel J, Agnihotri P, Tai-Seale M. Remote Patient Monitoring Technologies for Predicting Chronic Obstructive Pulmonary Disease Exacerbations: Review and Comparison. JMIR mHealth and uHealth 2020;8(5):e16147 View
  2. Mihălțan F, Coșei V, Borcea C, Constantin A. Telemedicine in chronic obstructive pulmonary disease: a possible transition to the patient independence. Pneumologia 2020;69(1):17 View
  3. Cazzola M, Cavalli F, Usmani O, Rogliani P. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 2020;17(5):635 View
  4. Kaye L, Gondalia R, Barrett M, Williams M, Stempel D. Concurrent Improvement Observed in Patient-Reported Burden and Sensor-Collected Medication Use Among Patients Enrolled in a COPD Digital Health Program. Frontiers in Digital Health 2021;3 View
  5. Jarrin R, Barrett M, Kaye L, Sayiner S, von Leer A, Johns J, D’Andrea L, Nunez C, Ostrovsky A. Need for clarifying remote physiologic monitoring reimbursement during the COVID-19 pandemic: a respiratory disease case study. npj Digital Medicine 2021;4(1) View
  6. Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A, Holzhauer B, Kaplan A, Clark A, Halpin D, Pinnock H, Chalmers J, van Boven J, Beeh K, Kostikas K, Roche N, Usmani O, Mastoridis P. Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes. Pragmatic and Observational Research 2021;Volume 12:25 View
  7. Holmes J, Heaney L. Measuring adherence to therapy in airways disease. Breathe 2021;17(2):210037 View
  8. Hong J, Wasden C, Han D. Introduction of digital therapeutics. Computer Methods and Programs in Biomedicine 2021;209:106319 View
  9. Chalupsky M, Craddock K, Schivo M, Kuhn B. Remote Patient Monitoring in the Management of Chronic Obstructive Pulmonary Disease. Journal of Investigative Medicine 2022;70(8):1681 View
  10. Krings J, Wojcik K, Chen V, Sekhar T, Harris K, Zulich A, Sumino K, Brownson R, Lenze E, Castro M. Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial. Trials 2022;23(1) View
  11. Garin N, Zarate-Tamames B, Gras-Martin L, Milà R, Crespo-Lessmann A, Curto E, Hernandez M, Mestres C, Plaza V. Clinical Impact of Electronic Monitoring Devices of Inhalers in Adults with Asthma or COPD: A Systematic Review and Meta-Analysis. Pharmaceuticals 2023;16(3):414 View
  12. Brown M, Knight M, Peters C, Maleki S, Motavalli A, Nedjat-Shokouhi B. Digital outpatient health solutions as a vehicle to improve healthcare sustainability—a United Kingdom focused policy and practice perspective. Frontiers in Digital Health 2023;5 View
  13. Inocencio T, Sterling K, Sayiner S, Minshall M, Kaye L, Hatipoğlu U. Budget impact analysis of a digital monitoring platform for COPD. Cost Effectiveness and Resource Allocation 2023;21(1) View